BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10249 related articles for article (PubMed ID: 1894771)

  • 1. Malignant schwannoma associated with xeroderma pigmentosum in a patient belonging to complementation group D.
    Nakamura T; Ono T; Yoshimura K; Arao T; Kondo S; Ichihashi M; Matsumoto A; Fujiwara Y
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 2):349-53. PubMed ID: 1894771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum group D patient bearing lentigo maligna without neurological symptoms.
    Fukuro S; Yamaguchi J; Mamada A; Kondo S; Satoh Y
    Dermatologica; 1990; 181(2):129-33. PubMed ID: 2242781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant trigeminal schwannoma associated with xeroderma pigmentosum--case report.
    Yamashiro S; Nagahiro S; Mimata C; Kuratsu J; Ushio Y
    Neurol Med Chir (Tokyo); 1994 Dec; 34(12):817-20. PubMed ID: 7532803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum variant associated with multiple cancers.
    Kuwamoto K; Miyauchi-Hashimoto H; Isei T; Horio T
    Photodermatol Photoimmunol Photomed; 1999; 15(3-4):127-32. PubMed ID: 10404723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of xeroderma pigmentosum group D determined by photobiological study.
    Ishii N; Nakajima H; Kondo S; Satoh Y; Fujiwara Y; Shimoda N
    J Dermatol; 1991 Jan; 18(1):31-5. PubMed ID: 2050904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basosquamous carcinoma and melanoma collision tumor in a child with xeroderma pigmentosum.
    Bostanci S; Akay BN; Kirmizi A; Okcu Heper A; Farabi B
    Pediatr Dermatol; 2020 Mar; 37(2):390-392. PubMed ID: 31957124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No apparent neurologic defect in a patient with xeroderma pigmentosum complementation group D.
    Ichihashi M; Yamamura K; Hiramoto T; Fujiwara Y
    Arch Dermatol; 1988 Feb; 124(2):256-60. PubMed ID: 3341805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late onset of skin cancers in 2 xeroderma pigmentosum group F siblings and a review of 30 Japanese xeroderma pigmentosum patients in groups D, E and F.
    Kondo S; Mamada A; Miyamoto C; Keong CH; Satoh Y; Fujiwara Y
    Photodermatol; 1989 Apr; 6(2):89-95. PubMed ID: 2664729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple melanoma in xeroderma pigmentosum].
    Fölster-Holst R; Schubert C; Christophers E
    Hautarzt; 1994 Aug; 45(8):554-61. PubMed ID: 7960757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xeroderma pigmentosum lesions related to ultraviolet transmittance by clothes.
    Bech-Thomsen N; Wulf HC; Ullman S
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 2):365-8. PubMed ID: 1999550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in photosensitivity and cellular sensitivity to ultraviolet B in a xeroderma pigmentosum group E patient.
    Kondo S; Fukuro S; Nishioka K
    Photodermatol Photoimmunol Photomed; 1991 Apr; 8(2):79-83. PubMed ID: 1756117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xeroderma pigmentosum complementation group E: a case report.
    Kawada A; Satoh Y; Fujiwara Y
    Photodermatol; 1986 Aug; 3(4):233-8. PubMed ID: 3774595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple melanomas occurring in a patient with xeroderma pigmentosum.
    Tullis GD; Lynde CW; McLean DI; Stewart WD
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 2):364-7. PubMed ID: 6480943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xeroderma pigmentosum variant associated with multiple skin cancers and a lung cancer.
    Mamada A; Miura K; Tsunoda K; Hirose I; Furuya M; Kondo S
    Dermatology; 1992; 184(3):177-81. PubMed ID: 1392108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xeroderma pigmentosum variant with multisystem involvement.
    Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
    Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study.
    Bhutto AM; Shaikh A; Nonaka S
    Br J Dermatol; 2005 Mar; 152(3):545-51. PubMed ID: 15787826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum.
    Grampurohit VU; Dinesh US; Rao R
    J Cancer Res Ther; 2011; 7(2):205-7. PubMed ID: 21768716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Xeroderma Pigmentosum].
    Nishigori C
    Brain Nerve; 2019 Apr; 71(4):394-399. PubMed ID: 30988228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiloculated lentigo maligna melanoma in a patient without evidence for xeroderma pigmentosum.
    Brandt O; Abeck D; Weichenthal M; Steinkraus V; Breitbart E; Jung EG; Ring J
    Acta Derm Venereol; 1995 Jul; 75(4):326-7. PubMed ID: 8578964
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed sensorineural deafness and skin carcinogenesis in a Japanese xeroderma pigmentosum group D patient.
    Mamada A; Kondo S; Kawada A; Satoh Y; Fujiwara Y
    Photodermatol; 1988 Apr; 5(2):83-91. PubMed ID: 3399439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 513.